World PulseNow
Newsletter

Novo Nordisk halts work on cell therapy for diabetes to cut costs, Bloomberg News reports

Investing.com•Friday, October 10, 2025 at 5:24:35 PM
NegativeFinancial Markets
Novo Nordisk halts work on cell therapy for diabetes to cut costs, Bloomberg News reports
Novo Nordisk has decided to halt its work on a promising cell therapy aimed at treating diabetes, a move that has raised concerns in the medical community. This decision, reported by Bloomberg News, is part of a broader cost-cutting strategy within the company. The implications of this halt are significant, as it may delay advancements in diabetes treatment and affect patients who are eagerly awaiting new options. The decision highlights the challenges pharmaceutical companies face in balancing innovation with financial sustainability.
— Curated by the World Pulse Now AI Editorial System
Read Original

Was this article worth reading? Share it

Recommended Readings
ETF IQ: Leveraged Single-Stock Funds Are Starting to Blow Up
Bloomberg13 hours ago
ETF IQ: Leveraged Single-Stock Funds Are Starting to Blow Up
NeutralFinancial Markets
In this week's ETF IQ, Katie Greifeld discusses the rising trend of leveraged single-stock funds within the $17 trillion global ETF industry. These funds are gaining attention for their potential to amplify returns, but they also come with increased risks. Understanding these dynamics is crucial for investors looking to navigate the complexities of the market.
Read full article
via Bloomberg
Novo Nordisk halts cell therapy work for diabetes as part of cost cuts
Investing.com15 hours ago
Novo Nordisk halts cell therapy work for diabetes as part of cost cuts
NegativeFinancial Markets
Novo Nordisk has decided to halt its cell therapy research aimed at treating diabetes as part of a broader cost-cutting strategy. This decision is significant as it reflects the challenges pharmaceutical companies face in balancing innovation with financial sustainability. The cessation of this promising research could delay advancements in diabetes treatment, impacting patients who rely on new therapies for better management of their condition.
Read full article
via Investing.com
Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push
Investing.com18 hours ago
Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push
PositiveFinancial Markets
Bristol Myers Squibb has made a significant move in the biotech sector by acquiring Orbital Therapeutics for $1.5 billion. This acquisition is a strategic step to enhance their cell therapy portfolio, which is crucial for addressing various diseases. It highlights Bristol Myers' commitment to innovation and growth in the field of advanced therapies, potentially leading to groundbreaking treatments for patients.
Read full article
via Investing.com
Novo Nordisk to acquire Akero Therapeutics in $5.2 billion deal to expand MASH treatments
Investing.com2 days ago
Novo Nordisk to acquire Akero Therapeutics in $5.2 billion deal to expand MASH treatments
PositiveFinancial Markets
Novo Nordisk has announced its acquisition of Akero Therapeutics for $5.2 billion, a strategic move aimed at enhancing its portfolio of MASH treatments. This deal is significant as it not only expands Novo Nordisk's capabilities in addressing metabolic diseases but also reflects the growing importance of innovative therapies in the healthcare sector. With this acquisition, Novo Nordisk is poised to strengthen its position in the market and potentially improve patient outcomes.
Read full article
via Investing.com
US approves some Nvidia UAE sales, Bloomberg News reports
Investing.com2 days ago
US approves some Nvidia UAE sales, Bloomberg News reports
PositiveFinancial Markets
The U.S. government has given the green light for certain sales of Nvidia products to the UAE, according to Bloomberg News. This approval is significant as it reflects a growing collaboration between American tech companies and international markets, particularly in the Middle East. Nvidia's advanced technology is crucial for various sectors, including artificial intelligence and data processing, and this move could enhance the UAE's technological landscape.
Read full article
via Investing.com
Warner Music in talks with Netflix for artist-based films, Bloomberg News reports
Investing.com2 days ago
Warner Music in talks with Netflix for artist-based films, Bloomberg News reports
PositiveFinancial Markets
Warner Music is reportedly in discussions with Netflix to create artist-based films, according to Bloomberg News. This collaboration could open new avenues for musicians to share their stories and connect with fans through cinematic experiences. It highlights the growing trend of merging music and film, which not only benefits the artists but also enriches the content offerings for streaming platforms.
Read full article
via Investing.com
Adicet Bio’s SWOT analysis: cell therapy stock faces pivotal moment
Investing.com3 days ago
Adicet Bio’s SWOT analysis: cell therapy stock faces pivotal moment
NeutralFinancial Markets
Adicet Bio is at a crucial juncture as it navigates the complexities of the cell therapy market. The company's recent SWOT analysis highlights its strengths, weaknesses, opportunities, and threats, providing insights into its potential for growth and challenges ahead. This analysis is significant as it helps investors and stakeholders understand the company's position and future prospects in a rapidly evolving industry.
Read full article
via Investing.com
Latest from Financial Markets
Trump ratchets up US-China trade war, promising new tariffs
Investing.coman hour ago
Trump ratchets up US-China trade war, promising new tariffs
NegativeFinancial Markets
Former President Trump has intensified the ongoing trade war between the U.S. and China by promising new tariffs on Chinese goods. This move could escalate tensions further, impacting global markets and trade relations. The implications of such tariffs could lead to increased prices for consumers and strain economic ties, making it a significant development in international trade.
Read full article
via Investing.com
What price loyalty? UK supermarket cards rated
The Guardianan hour ago
What price loyalty? UK supermarket cards rated
NeutralFinancial Markets
As grocery prices continue to rise, a recent evaluation of loyalty programs like Tesco's Clubcard and Sainsbury's Nectar reveals their potential benefits for consumers. With discounts on popular items, these schemes may help shoppers save money amidst increasing costs. Understanding the value of these loyalty cards is crucial for consumers looking to make informed choices about their grocery shopping.
Read full article
via The Guardian
Central London’s Exorbitant Rents Are Starting to Spill Over
Bloombergan hour ago
Central London’s Exorbitant Rents Are Starting to Spill Over
NegativeFinancial Markets
Central London's skyrocketing rents are becoming a pressing issue, as only the wealthiest tenants can afford to live in the city's most desirable neighborhoods. This trend is causing a ripple effect, pushing many residents to seek housing in less expensive areas, which could lead to significant changes in community dynamics and local economies. It's a situation that highlights the growing divide in urban living costs and raises questions about affordability and accessibility in one of the world's major cities.
Read full article
via Bloomberg
Trump Threatens 100% Tariffs on Chinese Goods
The New York Times2 hours ago
Trump Threatens 100% Tariffs on Chinese Goods
NegativeFinancial Markets
Former President Donald Trump has threatened to impose 100% tariffs on Chinese goods, a move that could escalate trade tensions between the U.S. and China. This threat comes as part of his ongoing criticism of China's trade practices, which he claims harm American businesses and workers. If implemented, such tariffs could lead to increased prices for consumers and further strain the already complicated U.S.-China relationship, making it a significant issue for both economies.
Read full article
via The New York Times
Trump threatens to impose additional 100% tariff on China and scrap Xi talks
France 242 hours ago
Trump threatens to impose additional 100% tariff on China and scrap Xi talks
NegativeFinancial Markets
US President Donald Trump has escalated tensions with China by threatening to impose a staggering 100% tariff on Chinese imports, effective November 1 or sooner. This move comes in response to China's new export controls on rare earth elements, which are crucial for various industries. Trump's comments also cast uncertainty on his planned meeting with Chinese leader Xi Jinping during his upcoming trip to South Korea. This situation is significant as it could further strain US-China relations and impact global markets.
Read full article
via France 24
Los Angeles Times Moves Closer to a Public Stock Offering
The New York Times2 hours ago
Los Angeles Times Moves Closer to a Public Stock Offering
PositiveFinancial Markets
The Los Angeles Times is taking significant steps towards a public stock offering, which could mark a new chapter in its financial journey. This move is important as it may provide the newspaper with the capital needed to invest in quality journalism and expand its reach, ultimately benefiting its readership and the media landscape.
Read full article
via The New York Times